ALKERMES reported 0 in Dividend Yield for its fiscal quarter ending in March of 2025.





Dy Change Date
AbbVie 2.91 0.58 Dec/2025
Amgen 2.95 0.38 Dec/2025
Bristol-Myers Squibb 0.22 0.04 Dec/2025
Coherus Biosciences 0 0 Mar/2025
Eli Lilly 0.58 0.16 Dec/2025
Gilead Sciences 2.58 0.25 Dec/2025
Heron Therapeutics 0 0 Mar/2025
J&J 2.5 0.32 Dec/2025
Merck 3.12 0.74 Dec/2025
Minerva Neurosciences 0 0 Mar/2025
Nektar Therapeutics 0 0 Mar/2025
Otsuka Holdings 1.46 0.19 Dec/2025
Ovoca Bio EUR 0 0 Dec/2024
Pfizer 6.91 0.33 Dec/2025
Regeneron Pharmaceuticals 0.46 0.01 Dec/2025